e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
New physiologic boundaries
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Effect of allogenic bone marrow transplant on cardiac function and pulmonary vascular pressure
E. Al Mutairy, N. Chaudhri, M. Al Jurf, A. Al Dalaan, S. Erwi, S. Saleemi, M. Khalid (Riyadh, Saudi Arabia)
Source:
Annual Congress 2013 –New physiologic boundaries
Session:
New physiologic boundaries
Session type:
Poster Discussion
Number:
4978
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Al Mutairy, N. Chaudhri, M. Al Jurf, A. Al Dalaan, S. Erwi, S. Saleemi, M. Khalid (Riyadh, Saudi Arabia). LATE-BREAKING ABSTRACT: Effect of allogenic bone marrow transplant on cardiac function and pulmonary vascular pressure. Eur Respir J 2013; 42: Suppl. 57, 4978
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Pulmonary hypertension after bone marrow transplantation in children
Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019
Year: 2019
Lung transplantation for pulmonary arterial hypertension
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015
Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016
Effects of transplantation on lung and exercise physiology
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220
Year: 2003
LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
Source: Eur Respir Rev, 26 (146) 170089; 10.1183/16000617.0089-2017
Year: 2017
Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012
Pirfenidone stabilizes pulmonary function and reduces
18
F-FDG-uptake in restrictive allograft syndrome following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Pulmonary distribution of oxygen partial pressure in lung transplant recipients: assessment by oxygen-sensitive
3
He-MRI to indicate bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005
LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation
Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease
Year: 2016
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Pulmonary involvement in haematological disorders and bone marrow transplant recipients
Source: Eur Respir Monogr 2019; 86: 333-358
Year: 2019
Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Source: Eur Respir J 2003; 21: 192-194
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept